IL11 and Myocardial fibrosis: Hence, it is likely that blockade of IL-11 (either in Il11-deficient mice or by IL-11–neutralizing antibodies), led to reduction in myocardial fibrosis and improvement of cardiac dysfunction through diminished ERK signaling and limited ECM production.13